-
Product Insights
New![]()
Dries Meganiese Dienste (Aj Van Wyk) Mine
The Dries Meganiese Dienste (Aj Van Wyk) Mine is a diamond mine in South Africa. It is currently in operation. Empower your strategies with our Dries Meganiese Dienste (Aj Van Wyk) Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RiMO-301 in Recurrent Head And Neck Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. RiMO-301 in Recurrent Head And Neck Squamous Cell Carcinoma Drug Details: RiMO-301 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INB-400 Autologous in Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. INB-400 Autologous in Glioblastoma Multiforme (GBM) Drug Details: INB-400 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rabies Vaccine 1 in Rabies
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rabies Vaccine 1 in Rabies Drug Details: Vaccine candidate is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TSI-GSD-104 in Eastern Equine Encephalitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TSI-GSD-104 in Eastern Equine Encephalitis Drug Details: TSI-GSD-104 is under investigation for the prevention of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INB-100 in Myelodysplastic Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INB-100 in Myelodysplastic Syndrome Drug Details:INB-100 is under development for the treatment of leukemia like acute and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – meningococcal [serotypes A, C, W-135, Y] (tetravalent) vaccine in Neisseria meningitidis Infections
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. meningococcal [serotypes A, C, W-135, Y] (tetravalent) vaccine in Neisseria meningitidis Infections Drug Details:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Budesonide in Asthma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Budesonide in AsthmaDrug Details:Budesonide is under development for the treatment of asthma. The drug candidate is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Thrombosomes in Hemostasis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Thrombosomes in Hemostasis Drug Details: Thrombosomes is under development for the treatment of wounds...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INB-400 in Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. INB-400 in Glioblastoma Multiforme (GBM) Drug Details: INB-400 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.